Journal of Young Pharmacists
Volume 3, Issue 2
2011 · pp. 81–168 · 15 articles
- Volume
- 3
- Issue
- 2
- Year
- 2011
- Published
- 19 Apr 2011
- Pages
- 81–168
- Articles
- 15
- Sections
- 8
- ISSN
- 0975-1505, 0975-1483
- Journal
- JYP
In this issue
Editorial

EditorialPublished: 19 Apr 2011
Mueen Ahmed KK
pp. 81-82 · DOI: 10.4103/0975-1483.80289Vol. 3, Issue 2 (2011)I welcome you to this second issue for the year 2011 comprising very interesting articles to read. We are proud to inform about the inclusion of our journal in SCImago Journal Ranking [SJR] recently. SJR is one of the tw…
Pharmaceutics

PharmaceuticsPublished: 19 Apr 2011
Chatterjee A, Bhowmik BB, Thakur YS
pp. 83-89 · DOI: 10.4103/0975-1483.80290Vol. 3, Issue 2 (2011)Inexpensive and female-controlled pre-exposure prophylaxis strategies to prevent mucosal transmission of the virus, is urgently needed with the rising prevalence of human immunodeficiency virus (HIV-1 and HIV2) infection…

PharmaceuticsPublished: 19 Apr 2011
Patel HP, Patel HK, Patel MP, Patel PR
pp. 90-96 · DOI: 10.4103/0975-1483.80291Vol. 3, Issue 2 (2011)The present invention relates to produce multiple unit particle system (MUPS) of stabilized ramipril pellets, hydrochlorothiazide, diluents, superdisintegrants, and lubricants which produce better dissolution of the syst…

PharmaceuticsPublished: 19 Apr 2011
Pandya N, Pandya M, Bhaskar VH
pp. 97-104 · DOI: 10.4103/0975-1483.80292Vol. 3, Issue 2 (2011)Floating microspheres have been utilized to obtain prolonged and uniform release of drug in the stomach for development of once-daily formulations. A controlled-release system designed to increase residence time in the s…

PharmaceuticsPublished: 19 Apr 2011
Bhoyar PK, Morani DO, Biyani DM, Umekar MJ, Mahure JG, Amgaonkar YM
pp. 105-111 · DOI: 10.4103/0975-1483.80293Vol. 3, Issue 2 (2011)The objective of this study was to microencapsulate the anti-inflammatory drug (naproxen) to provide controlled release and minimizing or eliminating local side effect by avoiding the drug release in the upper gastrointe…

PharmaceuticsPublished: 19 Apr 2011
Bhoyar PK, Amgaonkar YM
pp. 112-118 · DOI: 10.4103/0975-1483.80294Vol. 3, Issue 2 (2011)Metformin hydrochloride is an oral antidiabetic biguinide agent, used in the management of non-insulin-dependent (type-2) diabetes mellitus. The purpose of present work was to formulate tasteless complexes of metformin h…
Pharmacology

PharmacologyPublished: 19 Apr 2011
Shah JS, Goyal RK
pp. 119-124 · DOI: 10.4103/0975-1483.80296Vol. 3, Issue 2 (2011)Objectives:To investigate the neuropsychopharmacological effect of a polyherbal formulation (PHF) on the learning and memory processes in rats. Materials and Methods:PHF contains Withania somnifera (Ashwagandha), Nardost…

PharmacologyPublished: 19 Apr 2011
Ali N, Shah SWA, Shah I
pp. 125-128 · DOI: 10.4103/0975-1483.80300Vol. 3, Issue 2 (2011)The current work describes the antispasmodic action of Artemisia macrocephala, which is achieved via blocking of the calcium channels. This explains its traditional use as an antispasmodic.The crude methanolic extract of…

PharmacologyPublished: 19 Apr 2011
Nirmal SA, Laware RB, Rathi RA, Dhasade VV, Kuchekar BS
pp. 129-131 · DOI: 10.4103/0975-1483.80301Vol. 3, Issue 2 (2011)Bauhinia racemosa Lam. (Caesalpiniaceae) leaves have been used in the treatment of asthma traditionally and we therefore undertook this study to scientifically validate its benefit in asthma using suitable animal models.…
Pharmaceutical Chemistry

Pharmaceutical ChemistryPublished: 19 Apr 2011
Choudhary AN, Kohli MS, Kumar A, Joshi A
pp. 132-137 · DOI: 10.4103/0975-1483.80302Vol. 3, Issue 2 (2011)The compounds, 2-(methylsulfonyl)-1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indole-3-carboxylic acid (DM3), 2-(phenylsulfonyl)-1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indole-3-carboxylic acid (DM4), and 2-(p-toluenesulfonyl)- 1,2,3,…
Quality Assurance

Quality AssurancePublished: 19 Apr 2011
Patel KT, Chotai NP
pp. 138-150 · DOI: 10.4103/0975-1483.80303Vol. 3, Issue 2 (2011)‘If it’s not written down, then it didn’t happen!’ The basic rules in any good manufacturing practice (GMP) regulations specify that the pharmaceutical manufacturer must maintain proper documentation and records. Documen…
Pharmaceutical Education

Pharmaceutical EducationPublished: 19 Apr 2011
Khan TM, Anwar M, Mueen Ahmed KK
pp. 151-154 · DOI: 10.4103/0975-1483.80304Vol. 3, Issue 2 (2011)This perspective is a reflection of the Personal teaching experience of the authors. The aim of this perspective is to identify the weaknesses in the pharmacy curriculum development in Asian developing nations and to pro…
Pharmaceutical Marketing and Management

Pharmaceutical Marketing and ManagementPublished: 19 Apr 2011
Pateriya S, Janodia MD, Deshpande PB, Ligade VS, Talole KB, Kulshrestha T, Kamariya Y, Musmade PB, Udupa N
pp. 155-162 · DOI: 10.4103/0975-1483.80305Vol. 3, Issue 2 (2011)The Gulf cooperation council (GCC) region is considered as “Emerging market” for pharmaceutical export and bilateral trade. The understanding of the regulatory requirements of this region can be beneficial for pharmaceut…

Pharmaceutical Marketing and ManagementPublished: 19 Apr 2011
Joshi Y, Kothiyal P
pp. 163-166 · DOI: 10.4103/0975-1483.80306Vol. 3, Issue 2 (2011)Pharmaceutical pictograms have the potential to play an important role in optimizing compliance in the illiterate patient population. Pictograms may improve warning comprehension for those with visual or literacy difficu…
Letter to the Editor

Letter to the EditorPublished: 19 Apr 2011
Jaykaran, J, Chavda N, Yadav P
pp. 167-168 · DOI: 10.4103/0975-1483.80308Vol. 3, Issue 2 (2011)Sir, It is observed that the clinical trials published in various medical journals are poor in reporting of various methodological aspects, including sample size calculation and power.[1] It is difficult to generalize th…

